(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells

Cancer Detection and Prevention

Volumn 31, Issue 6, 2007, Pages 499-504

  Farabegoli, Fulvia ^a   Barbi, Cristiana ^a   Lambertini, Elisabetta ^b   Piva, Roberta ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Chemoprevention; Endocrine therapy; Estrogen receptor signaling; Green tea; ICI 182,780; MDA MB 231; MTT assay; pS2; RT PCR; Tamoxifen

Indexed keywords

EPIGALLOCATECHIN GALLATE; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; STEROID RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CARCINOMA; CELL KILLING; CELL LINE; CELL STRAIN MCF 7; CELL VIABILITY; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CATECHIN; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; TAMOXIFEN; TUMOR SUPPRESSOR PROTEINS;

EID: 36549039923     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.10.018     Document Type: Article

References (25)

1. Inoue M., Tajima K., Hirose N., Hamajima T., Takezaki T., Kuroishi, et al. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control 9 (1998) 209-216
2. Chung F.L., Schwartz J., Herzog C.R., and Yang Y.M. Tea and cancer prevention: studies in animals and humans. J Nutr 33 (2003) 3268S-3274S
3. Crespy V., and Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134 12 Suppl (2004) 3431S-3440S
4. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu Y., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63 (2003) 7563-7570
5. Park O.J., and Surh Y.-J. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150 (2004) 43-56
6. Farabegoli F. Green tea in human cancer. Minerva Biotec 17 (2005) 163-173
7. Goodin M.G., Fertuk K.C., Zacharewsski T.R., and Rosengren R.J. Estrogen receptor-mediated action of polyphenolic catechins in vivo and in vitro. Toxicol Sci 69 (2002) 361-364
8. Kuruto-Niwa R., Inoue S., Ogawa S., Maramatsu M., and Nozawa R. Effect of tea catechins on the ERE-regulated estrogenic activity. J Agric Food Chem 48 (2000) 6355-6361
9. Wu A.H., Tseng C.-C., Van Den Berg D., and Yu M.C. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 63 (2003) 7526-7529
10. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N Engl J Med 354 (2006) 270-282
11. Nicholson R.I., and Jonhston S.R. Endocrine therapy-current benefits and limitations. Breast Cancer Res Treat 93 Suppl 1 (2005) S3-S10
12. Brown A.M., Jeltsch J.M., Roberts M., and Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81 (1984) 6344-6348
13. Meuller S.O. Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J Chromatogr B 777 (2002) 155-165
14. Lewis-Wambi J.S., and Jordan V.C. Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs). Breast Dis 24 (2005-2006) 93-105
15. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
16. Qiu Y., Waters C.E., Lewis A.E., Langman M.J., and Eggo M.C. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 174 (2002) 369-377
17. Banerjee S., Sengupta K., Saxena N.K., Dhar K., and Banerjee S.K. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks. Mol Cancer Res 3 (2005) 151-162
18. Foster J.S., Henley D.C., Ahamed S., and Wimalasena J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 12 (2001) 320-327
19. Perillo B., Sasso A., Abbondanza C., and Palumbo G. 17beta-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20 (2000) 2890-2901
20. Howell S.J., Johnston S.R., and Howell A. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Best Pract Res Clin Endocrinol Metab 18 (2004) 47-66
21. Sartippour M.R., Pietras R., Marquez-Garban D.C., Chen H.W., Heber D., Henning S.M., et al. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 12 (2006) 2424-2433
22. Belguise K., Guo S., and Sonenshein G.E. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 67 12 (2007) 5763-5770
23. Sun C.L., Yuan J.M., Koh W.P., and Yu M.C. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27 7 (2006) 1301-1924
24. Vergote D., Cren-Olive C., Chopin V., Toillon R.A., Rolando C., Hondermarck H., et al. (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Res Treat 76 (2002) 195-201.25
25. Chisholm K., Bray B.J., and Rosengren R.J. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 15 (2004) 889-897